The University of Chicago Header Logo

Connection

Thomas F. Gajewski to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Thomas F. Gajewski has written about Radiopharmaceuticals.
Thomas F. Gajewski
Connection Strength
0.111
Radiopharmaceuticals
  1. Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma. Cancer Imaging. 2014 Nov 12; 14:30.
    View in: PubMed
    Score: 0.111
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.